Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vasogliz M Plus 80mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Vasolife Healthcare

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Vasogliz M Plus 80mg/500mg Tablet SR

Glycomet M Plus 80mg/500mg extended-release tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical supervision risks elevated glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is one component of a comprehensive diabetes management plan, encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. To mitigate hypoglycemia, maintain regular meals and carry a readily available glucose source, such as candy or juice. Alcohol consumption should be avoided due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may also occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Its suitability for pregnant or breastfeeding individuals requires medical consultation. Regular blood glucose monitoring is essential, alongside potential blood tests to assess blood cell counts and liver function as advised by your doctor.

Uses of Vasogliz M Plus 80mg/500mg Tablet SR

Adult-onset diabetes

Major Benefits of Vasogliz M Plus 80mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Vasogliz M Plus 80mg/500mg Tablet SR. Ingest the tablet whole; do not crush, chew, or divide it. Administer this medication with food.

Common Side effects of Vasogliz M Plus 80mg/500mg Tablet SR:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Vasogliz M Plus 80mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Vasogliz M Plus 80mg/500mg Tablet SR whole; do not chew, crush, or divide it. Administer this medication with a meal.

How Vasogliz M Plus 80mg/500mg Tablet SR works:

Gliclazide and Metformin, combined in the extended-release Vasogliz M Plus 80mg/500mg tablet, offer dual-action diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining alcohol and Vasogliz M Plus 80mg/500mg SR tablets poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Vasogliz M Plus 80mg/500mg SR tablets during pregnancy carries a confirmed risk to the fetus. While generally contraindicated, a physician might exceptionally prescribe it in critical circumstances where potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Prolonged-release Vasogliz M Plus 80mg/500mg tablets are likely unsuitable for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Vasogliz M Plus 80mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. The medication is contraindicated in patients with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Vasogliz M Plus 80mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Individuals with mild to moderate liver disease should begin with a reduced dose; the medication is contraindicated for those with severe hepatic dysfunction. Physician consultation is advised.

What if you forget to take Vasogliz M Plus 80mg/500mg Tablet SR :

Should you forget to take a Vasogliz M Plus 80mg/500mg Tablet SR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vasogliz M Plus 80mg/500mg Tablet SR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Vasogliz M Plus 80mg/500mg Tablet SR

Vasogliz M Plus 80mg/500mg SR tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It is not suitable for type 1 diabetes.
Vasogliz M Plus 80mg/500mg SR tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, can also occur. Prolonged use may result in vitamin B12 deficiency.
Vasogliz M Plus 80mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Vasogliz M Plus 80mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is less likely to occur if you avoid using this medication if you have kidney disease, are elderly, or consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue use and seek immediate medical attention.
Prolonged use of Vasogliz M Plus 80mg/500mg SR tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Vasogliz M Plus 80mg/500mg SR tablets are contraindicated in patients with allergies to any ingredient or excipient, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Consuming alcohol with Vasogliz M Plus 80mg/500mg Tablet SR is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Vasogliz M Plus 80mg/500mg SR tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Vasogliz M Plus 80mg/500mg SR tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, can also occur. Prolonged use may result in vitamin B12 deficiency.
Vasogliz M Plus 80mg/500mg SR tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry glucose tablets, honey, or fruit juice.
Vasogliz M Plus 80mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is less likely in patients without kidney disease, who are not elderly, and who do not consume large amounts of alcohol. Symptoms may include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or a slow heart rate. If you experience these, discontinue Vasogliz M Plus 80mg/500mg Tablet SR and seek immediate medical attention.
Prolonged use of Vasogliz M Plus 80mg/500mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Patients with a known allergy to Vasogliz M Plus 80mg/500mg Tablet SR components or excipients, or those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis), should not use this medication.
Consuming alcohol with Vasogliz M Plus 80mg/500mg Tablet SR is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Vasogliz M Plus 80mg/500m...
71
MRP 82
13% off